Britain is spending more on its National Health Service than at any point in its 78-year history. The 2025/26 NHS England budget sits at roughly £192 billion, a figure that would have seemed fantastical to Aneurin Bevan’s cabinet. And yet the waiting list for elective treatment still hovers above six million people, ambulance response times in many regions remain well outside their targets, and the ONS estimates that NHS healthcare productivity is still below its pre-pandemic level. More money. Slower service. The paradox sits at the centre of almost every political argument about public spending, and nobody in Westminster has a convincing answer for it.
I’ve read a great deal of think-tank analysis on this, and what strikes me is how rarely the conversation goes beyond the surface. The usual suspects get wheeled out: agency staff costs, an ageing population, the aftermath of Covid-19. All true, all partial. The fuller picture is considerably more uncomfortable, and it implicates not just funding levels but the structural logic of how a very large, very complex institution actually absorbs money.
What the productivity data actually shows
The ONS public services productivity estimates for healthcare are, by any measure, grim reading. Output rose sharply with the return of elective activity post-pandemic, but inputs, meaning staff costs, consumables, and estate spending, rose faster still. The Health Foundation, in its 2025 analysis of NHS performance, calculated that activity per unit of resource had fallen roughly 20 per cent compared with pre-2020 trends. In plain terms: we are getting less clinical work done per pound spent than we were five years ago.
Part of this is explainable. Agency and locum staff became vastly more expensive as the NHS competed with a depleted labour market; the costs of infection control and personal protective equipment lingered longer than anticipated; and the capital programme, which should fund efficiency-improving technology, was repeatedly raided to cover day-to-day operational deficits. The last point matters more than it is generally acknowledged. When trusts borrow from their capital allocation to balance a revenue budget, they are essentially trading long-term capacity for short-term solvency. New MRI scanners don’t get bought. Electronic patient record systems stall. The backlog of maintenance on NHS buildings, already a familiar story in other parts of Britain’s built environment, compounds every year.
Regional performance gaps that the national headlines miss
NHS England is not one organisation. It is 42 integrated care systems, each with a different demographic profile, estate, workforce mix, and financial position. The national waiting list figure flattens what are, in practice, wildly divergent realities. In some parts of the South East, trusts are meeting the 18-week referral-to-treatment standard for the majority of specialties. In parts of the North East and Yorkshire, patients are routinely waiting well beyond a year for orthopaedic or ophthalmology procedures.
The King’s Fund has pointed to what it calls a “funding-follows-failure” dynamic: systems that have historically been underfunded relative to their deprivation and age profiles receive emergency bailouts rather than sustained investment, which distorts incentives and prevents the kind of planned workforce growth that actually improves throughput. It is a pattern I find deeply frustrating, because it means that the places with the greatest clinical need are also the ones least able to plan. Long-term sickness rates, which are already placing enormous pressure on the wider workforce, are highest in precisely those same regions, creating a self-reinforcing loop of demand and capacity failure.
The workforce problem money alone cannot solve
The NHS Long Term Workforce Plan, published in 2023 and running through to 2037, commits to training significantly more doctors, nurses, and allied health professionals. The ambition is correct. The timeline, however, is measured in decades, and the attrition problem remains largely unaddressed. NHS Digital data shows that roughly one in nine nursing posts was vacant as recently as late 2024, and retention among newly qualified nurses is markedly worse than it was a decade ago. You can fund training places generously and still see net workforce numbers stagnate if the conditions driving experienced staff out of the profession are not fixed.
Pay is one lever. Working conditions are another. But there is also a structural issue that gets less attention: NHS community pharmacy has been systematically defunded for years, pushing activity that should be handled in a chemist’s consultation room back into GP surgeries and, ultimately, hospital outpatient departments. As I’ve written about in examining the collapse of community pharmacies across Britain, that system is fracturing in ways that add measurable cost and delay to the secondary care pipeline. It is a reminder that NHS productivity cannot be understood by looking at acute trusts in isolation.
Technology: the promised solution that keeps being deferred
Every NHS strategy document of the past fifteen years has featured digital transformation as a central efficiency driver. Electronic patient records, AI-assisted diagnostics, remote monitoring of long-term conditions: the theory is sound, and the evidence from health systems in Denmark and the Netherlands suggests genuine gains are possible. The problem in England is implementation. The NHS App now has more than 35 million registered users, which is genuinely impressive. But interoperability between hospital systems remains patchy; a patient seen at one trust often arrives at another with no accessible record. The result is duplicated tests, repeated consultations, and clinician time spent on administrative reconstruction rather than clinical decision-making.
The irony is that digital investment is one area where the capital-raiding problem bites hardest. Technology projects require upfront capital, deliver returns over years, and are easy to cut when a trust’s finance director is facing a £40 million in-year deficit. It’s the same logic that leads organisations to defer maintenance until a roof collapses. Some trusts have navigated this well; the same discipline that separates effective digital transformation from chaos is not unlike the discipline required to recover from structural problems in other complex systems, which is why outfits like Search Engine Tuning tend to emphasise systematic diagnosis before intervention. Treating symptoms without understanding root cause is expensive in any domain.
What would actually move the dial
Three things, in my reading of the evidence. First, a genuine ring-fence on capital budgets, with legal consequences for raiding them, to force the infrastructure investment that productivity gains depend on. Second, a workforce strategy that takes retention as seriously as recruitment, which means addressing rostering, professional development, and the grinding administrative burden that drives burnout. Third, a frank renegotiation of what the NHS is expected to deliver, given demographic reality. England’s over-sixties cohort is growing, living longer, and arriving at hospital with more complex, multi-system conditions. The model that worked for a younger, healthier population requires substantive redesign, not incremental tweaks.
None of this is cheap. None of it is fast. And none of it fits neatly onto a political campaign leaflet. The NHS productivity crisis is not a conspiracy or a failure of will; it is the result of decades of structural decisions accumulating into a system under strain that additional money, poured in without structural reform, cannot simply bail out. The spending matters. How it is spent matters considerably more.
Frequently Asked Questions
Why is NHS productivity falling despite record spending?
The ONS estimates that NHS healthcare output per unit of resource remains below pre-pandemic levels because input costs, particularly agency staff, infection control, and deferred maintenance, rose faster than clinical activity recovered. Capital budgets have also been repeatedly diverted to cover day-to-day deficits, starving investment in the technology that drives long-term efficiency gains.
What is the NHS waiting list situation in England in 2026?
The elective treatment waiting list in England remains above six million people, with significant regional variation. Patients in parts of the North East and Yorkshire face substantially longer waits than those in the South East for the same procedures, reflecting historical underfunding relative to local deprivation and age profiles.
How does the NHS compare to other countries on productivity?
Health systems in Denmark and the Netherlands have achieved measurably better interoperability between digital records and primary and secondary care, which reduces duplicated tests and improves throughput. The NHS lags on system-to-system data sharing despite strong individual digital tools like the NHS App, which has more than 35 million registered users.
What is the NHS Long Term Workforce Plan and will it fix the staffing crisis?
Published in 2023, the plan commits to training significantly more doctors and nurses through to 2037. Critics argue it addresses recruitment but not retention; NHS Digital data shows roughly one in nine nursing posts was vacant in late 2024, and attrition among newly qualified nurses is worse than it was a decade ago.